Intec Pharma Nominates John Kozarich As Chairman Of Board – Quick Facts
5/16/2016 8:50 AM ET
Intec Pharma Ltd. (NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary drug delivery platform technology, the Accordion Pill, said that its board of directors has nominated Dr. John Kozarich to act as its chairman.
Dr. Kozarich has nearly 40 years of experience in the biopharmaceutical industry and academia. Since 2007, he has served as Chairman of Ligand Pharmaceuticals, Inc. (LGND), a biopharmaceutical company.
Ligand has partnerships and license agreements with 85 pharmaceutical and biotechnology companies, over 30 of which are accessing Ligand’s proprietary drug delivery technology, Captisol.